The landscape for activist short sellers faces a new legal hurdle in Texas, where an appellate court has revived a business disparagement claim brought by a farmland-focused real estate investment trust (REIT) against a local hedge fund. The litigation centers on allegations that the hedge fund played an active role in the creation and dissemination of a critical report while simultaneously maintaining a short position in the REIT's stock. By allowing the business disparagement claims to proceed, the court has signaled that the intersection of short-selling research and potential defamation remains a high-risk area for firms that coordinate closely with third-party authors. This development is particularly notable given the current climate of heightened regulatory and judicial scrutiny surrounding short-seller conduct, which has already seen landmark fraud convictions in other jurisdictions. For investors, this case serves as a reminder that the 'research' provided by activist firms is increasingly subject to the same legal standards as traditional corporate communications, particularly when financial incentives are directly tied to the publication's impact on market sentiment. The Forensic Ledger notes that while short sellers often rely on First Amendment protections for their commentary, the threshold for 'business disparagement'—which focuses on the economic harm caused by false statements—may provide a more effective path for companies seeking to challenge aggressive short campaigns. ## Sources - Law360 — Texas appellate court revives REIT's claims over short seller article, October 17, 2026.
Original reporting by Law360. This article is desk analysis prepared by The Forensic Ledger from publicly available sources, summarized with citation to the original.
Not investment advice. This is original reporting and analysis prepared by The Forensic Ledger from publicly available data. Nothing here is a recommendation to buy, sell, or hold any security. Always consult the original source and a licensed professional. See our full disclaimer and source-citation policy.
